Histiocytic Disorder Follow-up Study
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The purpose of the study is to describe the burden of chronic health conditions, psychological dysfunction, chronic pain, healthcare utilization, worse health-related quality of life, overall mortality, and cause-specific mortality among individuals with histiocytic disorders
Eligibility
Participation Requirements
Sex: All
Maximum Age: 89
Healthy Volunteers: f
View:
• diagnosis of histiocytic disorder at any age
‣ Langerhans cell histiocytosis,
⁃ Erdheim-Chester disease,
⁃ Rosai-Dorfman disease,
⁃ Xanthogranuloma,
⁃ Mixed histiocytosis
⁃ Malignant histiocytosis (Histiocytic sarcoma, langerhans cell sarcoma, interdigitating cell sarcoma)
⁃ Hemophagocytic lymphohistiocytosis
Locations
United States
Alabama
University of Alabama at Birmingham
RECRUITING
Birmingham
Contact Information
Primary
Gaurav Goyal, MD
histio@uabmc.edu
1-866-438-1640
Time Frame
Start Date: 2022-09-01
Estimated Completion Date: 2028-12
Participants
Target number of participants: 6000
Related Therapeutic Areas
Sponsors
Leads: University of Alabama at Birmingham